BACH BOLIGCENTER ApS: Financial statements 2023
CVR: 12024584
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -15,335 and a net result of DKK -200,720 compared with DKK -153,237 the year before. Equity in the 2023 report amounted to DKK 424,365. The solvency ratio was 95.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -15,335
- Profit/Loss
- DKK -200,720
- Equity
- DKK 424,365
- Total Assets
- DKK 444,644
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -15K | -201K | 424K | 1 |
| 2022 | - | -14K | -153K | 682K | 1 |
| 2021 | - | -13K | -9K | 892K | 1 |
| 2020 | - | -14K | -166K | 956K | 0 |
| 2019 | - | -17K | 12K | 1.2M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.
